Aquestive therapeutics to host investor & analyst virtual epinephrine drug delivery r&d event on march 25 at 9:00 a.m. et

Warren, n.j., march 05, 2021 (globe newswire) -- aquestive therapeutics, inc. (nasdaq: aqst), a pharmaceutical company focused on developing and commercializing differentiated products that address patients' unmet needs and solve therapeutic problems, announced today that it will host a virtual investor and analyst epinephrine drug delivery research and development event on thursday, march 25, 2021 at 9:00 am et.
AQST Ratings Summary
AQST Quant Ranking